Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults
Clinical trial NCT04625972 · COMPLETED
Trial details
- NCT number
- NCT04625972
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2021-04-07
- Enrollment
- 1131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.